CD19 drugs for Large B-Cell Lymphoma

2 tracked CD19 drugs in the Large B-Cell Lymphoma race. The class explanation lives on the CD19 page; the full indication pipeline across every mechanism is on the Large B-Cell Lymphoma page.

1 approved / phase 41 Phase 2

Head-to-head evidence: cemacabtagene ansegedleucel vs Tafasitamab

The roster

← all CD19 drugs